What is Generation Bio Co?
, a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 35.98M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.